Michael Birrer on Predicting Outcomes in Ovarian Cancer

Video

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that influence long-term survival in patients and survivors with ovarian cancer.

Michael Birrer, MD, PhD, Harvard Medical School, discusses what he hopes to discover as factors that may influence long-term survival in patients and survivors of ovarian cancer.

Birrer is involved in a study examining psychosocial, quality of life, and genomic factors at diagnosis that correlate with survival lasting longer than 10 years. Hopefully, he says, this will lead to more personalized medicine so that every patient with ovarian cancer can become a long-term survivor.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Image of a woman wearing a patterned shirt in front of a dark blue background
Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
3 experts in this video
3 experts in this video
Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
Related Content
AI-generated graphic of cancer cells

T-DXd Rechallenge Tolerable Post Grade 1 ILD in Breast, Solid Tumors

Chris Ryan
June 2nd 2025
Article

Seventy-three percent of patients with breast and other solid tumors did not experience ILD recurrence when rechallenged with trastuzumab.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Line illustration of a clipboard that says "FDA" with an approval mark in front on a cornflower blue background

A Snapshot of April FDA Approvals in Oncology for Nurses and APPs

Bridget Hoyt
May 1st 2025
Article

Approvals in oncology during April included treatments for breast cancer, colorectal cancer, and more.

Oncology Nursing News

A Look Back at 2022 FDA Approvals in Oncology

Oncology Nursing News
January 2nd 2023
Podcast

In this episode of The Vitals, we recount the oncology drugs that received FDA approvals in 2022.

Photo of a nurse holding a clipboard and talking to a patient

Patient-Centered Communication Drives Supportive Care Needs in Incurable Cancer

Kristie L. Kahl
April 16th 2025
Article

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable gynecologic cancer treatment.

Photo of a woman with her hand on her forehead in stress

Opinion: Crowdfunding Falls Short in Gynecologic Cancer

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
Published: April 14th 2025 | Updated: April 16th 2025
Article

Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing emotional support.